TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
- PMID: 31207605
- DOI: 10.1038/s41586-019-1326-9
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
Abstract
Cytotoxic T cells are essential mediators of protective immunity to viral infection and malignant tumours and are a key target of immunotherapy approaches. However, prolonged exposure to cognate antigens often attenuates the effector capacity of T cells and limits their therapeutic potential1-4. This process, known as T cell exhaustion or dysfunction1, is manifested by epigenetically enforced changes in gene regulation that reduce the expression of cytokines and effector molecules and upregulate the expression of inhibitory receptors such as programmed cell-death 1 (PD-1)5-8. The underlying molecular mechanisms that induce and stabilize the phenotypic and functional features of exhausted T cells remain poorly understood9-12. Here we report that the development and maintenance of populations of exhausted T cells in mice requires the thymocyte selection-associated high mobility group box (TOX) protein13-15. TOX is induced by high antigen stimulation of the T cell receptor and correlates with the presence of an exhausted phenotype during chronic infections with lymphocytic choriomeningitis virus in mice and hepatitis C virus in humans. Removal of its DNA-binding domain reduces the expression of PD-1 at the mRNA and protein level, augments the production of cytokines and results in a more polyfunctional T cell phenotype. T cells with this deletion initially mediate increased effector function and cause more severe immunopathology, but ultimately undergo a massive decline in their quantity, notably among the subset of TCF-1+ self-renewing T cells. Altogether, we show that TOX is a critical factor for the normal progression of T cell dysfunction and the maintenance of exhausted T cells during chronic infection, and provide a link between the suppression of effector function intrinsic to CD8 T cells and protection against immunopathology.
Similar articles
-
TOX is a critical regulator of tumour-specific T cell differentiation.Nature. 2019 Jul;571(7764):270-274. doi: 10.1038/s41586-019-1324-y. Epub 2019 Jun 17. Nature. 2019. PMID: 31207604 Free PMC article.
-
Transcription Factor IRF4 Promotes CD8+ T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection.Immunity. 2017 Dec 19;47(6):1129-1141.e5. doi: 10.1016/j.immuni.2017.11.021. Epub 2017 Dec 12. Immunity. 2017. PMID: 29246443
-
Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14113-14118. doi: 10.1073/pnas.1903520116. Epub 2019 Jun 21. Proc Natl Acad Sci U S A. 2019. PMID: 31227606 Free PMC article.
-
Role, function and regulation of the thymocyte selection-associated high mobility group box protein in CD8+ T cell exhaustion.Immunol Lett. 2021 Jan;229:1-7. doi: 10.1016/j.imlet.2020.11.004. Epub 2020 Nov 11. Immunol Lett. 2021. PMID: 33186634 Review.
-
CD8 T cell dysfunction during chronic viral infection.Curr Opin Immunol. 2007 Aug;19(4):408-15. doi: 10.1016/j.coi.2007.06.004. Epub 2007 Jul 25. Curr Opin Immunol. 2007. PMID: 17656078 Review.
Cited by
-
Stepwise Tfh cell differentiation revisited: new advances and long-standing questions.Fac Rev. 2021;10:3. doi: 10.12703/r/10-3. Epub 2021 Jan 15. Fac Rev. 2021. PMID: 33644779 Free PMC article.
-
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes.Mol Cancer. 2024 Sep 9;23(1):193. doi: 10.1186/s12943-024-02104-w. Mol Cancer. 2024. PMID: 39251981 Free PMC article. Review.
-
The effector program of human CD8 T cells supports tissue remodeling.J Exp Med. 2024 Feb 5;221(2):e20230488. doi: 10.1084/jem.20230488. Epub 2024 Jan 16. J Exp Med. 2024. PMID: 38226976 Free PMC article.
-
TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer.Front Immunol. 2021 Apr 9;12:647540. doi: 10.3389/fimmu.2021.647540. eCollection 2021. Front Immunol. 2021. PMID: 33897695 Free PMC article.
-
Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities.J Biomed Sci. 2023 Jan 10;30(1):3. doi: 10.1186/s12929-022-00893-0. J Biomed Sci. 2023. PMID: 36627707 Free PMC article. Review.
References
-
- Wherry, E. J. T cell exhaustion. Nat. Immunol. 12, 492–499 (2011). - DOI
-
- Speiser, D. E. et al. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat. Rev. Immunol. 14, 768–774 (2014). - DOI
-
- Schietinger, A. & Greenberg, P. D. Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol. 35, 51–60 (2014). - DOI
-
- Gallimore, A., Hengartner, H. & Zinkernagel, R. Hierarchies of antigen-specific cytotoxic T-cell responses. Immunol. Rev. 164, 29–32 (1998). - DOI
-
- Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687 (2006). - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials